De‐Shen Wang

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Rui‐Hua Xu · 7 shared papers, 2012–2019 · strength 0.30
   • Paper The efficacy and safety of modified FOLFIRINOX as first-line chemotherapy for Chinese patients with metastatic pancreat… DOI 10.1186/s40880-019-0367-7↗
   • Paper Pathologic Diagnosis of Pancreatic Adenocarcinoma in the United States: Its Status and Prognostic Value. DOI 10.7150/jca.14185↗
   • Paper Reduced expression of p21-activated protein kinase 1 correlates with poor histological differentiation in pancreatic ca… DOI 10.1186/1471-2407-14-650↗
2. Yuhong Li · 4 shared papers, 2012–2019 · strength 0.20
   • Paper The efficacy and safety of modified FOLFIRINOX as first-line chemotherapy for Chinese patients with metastatic pancreat… DOI 10.1186/s40880-019-0367-7↗
   • Paper Pathologic Diagnosis of Pancreatic Adenocarcinoma in the United States: Its Status and Prognostic Value. DOI 10.7150/jca.14185↗
   • Paper Phase I/II study of albumin-bound nab-paclitaxel plus gemcitabine administered to Chinese patients with advanced pancre… DOI 10.1007/s00280-013-2102-4↗
3. Feng‐Hua Wang · 3 shared papers, 2012–2019 · strength 0.17
   • Paper The efficacy and safety of modified FOLFIRINOX as first-line chemotherapy for Chinese patients with metastatic pancreat… DOI 10.1186/s40880-019-0367-7↗
   • Paper Pathologic Diagnosis of Pancreatic Adenocarcinoma in the United States: Its Status and Prognostic Value. DOI 10.7150/jca.14185↗
   • Paper ABO blood group, hepatitis B viral infection and risk of pancreatic cancer. DOI 10.1002/ijc.26376↗
4. Miao‐Zhen Qiu · 4 shared papers, 2012–2016 · strength 0.15
   • Paper Pathologic Diagnosis of Pancreatic Adenocarcinoma in the United States: Its Status and Prognostic Value. DOI 10.7150/jca.14185↗
   • Paper Phase I/II study of albumin-bound nab-paclitaxel plus gemcitabine administered to Chinese patients with advanced pancre… DOI 10.1007/s00280-013-2102-4↗
   • Paper Comparison of the prognostic values of various inflammation based factors in patients with pancreatic cancer. DOI 10.1007/s12032-012-0226-8↗
5. Zhi‐Qiang Wang · 2 shared papers, 2012–2019 · strength 0.12
   • Paper The efficacy and safety of modified FOLFIRINOX as first-line chemotherapy for Chinese patients with metastatic pancreat… DOI 10.1186/s40880-019-0367-7↗
   • Paper ABO blood group, hepatitis B viral infection and risk of pancreatic cancer. DOI 10.1002/ijc.26376↗
6. Le Zhang · 2 shared papers, 2012–2019 · strength 0.12
   • Paper The efficacy and safety of modified FOLFIRINOX as first-line chemotherapy for Chinese patients with metastatic pancreat… DOI 10.1186/s40880-019-0367-7↗
   • Paper Are risk factors associated with outcomes in pancreatic cancer? DOI 10.1371/journal.pone.0041984↗
7. Dong-sheng Zhang · 3 shared papers, 2012–2013 · strength 0.10
   • Paper Phase I/II study of albumin-bound nab-paclitaxel plus gemcitabine administered to Chinese patients with advanced pancre… DOI 10.1007/s00280-013-2102-4↗
   • Paper Comparison of the prognostic values of various inflammation based factors in patients with pancreatic cancer. DOI 10.1007/s12032-012-0226-8↗
   • Paper Are risk factors associated with outcomes in pancreatic cancer? DOI 10.1371/journal.pone.0041984↗
8. Ting Deng · 1 shared paper, 2019 · strength 0.09
   • Paper The efficacy and safety of modified FOLFIRINOX as first-line chemotherapy for Chinese patients with metastatic pancreat… DOI 10.1186/s40880-019-0367-7↗
9. Fei Zhang · 1 shared paper, 2019 · strength 0.09
   • Paper The efficacy and safety of modified FOLFIRINOX as first-line chemotherapy for Chinese patients with metastatic pancreat… DOI 10.1186/s40880-019-0367-7↗
10. Wei Wang · 1 shared paper, 2019 · strength 0.09
    • Paper The efficacy and safety of modified FOLFIRINOX as first-line chemotherapy for Chinese patients with metastatic pancreat… DOI 10.1186/s40880-019-0367-7↗
11. Yi Ba · 1 shared paper, 2019 · strength 0.09
    • Paper The efficacy and safety of modified FOLFIRINOX as first-line chemotherapy for Chinese patients with metastatic pancreat… DOI 10.1186/s40880-019-0367-7↗
12. Dongsheng Zhang · 2 shared papers, 2012–2016 · strength 0.08
    • Paper Pathologic Diagnosis of Pancreatic Adenocarcinoma in the United States: Its Status and Prognostic Value. DOI 10.7150/jca.14185↗
    • Paper ABO blood group, hepatitis B viral infection and risk of pancreatic cancer. DOI 10.1002/ijc.26376↗
13. Feng Wang · 1 shared paper, 2016 · strength 0.05
    • Paper Pathologic Diagnosis of Pancreatic Adenocarcinoma in the United States: Its Status and Prognostic Value. DOI 10.7150/jca.14185↗
14. Shuqiang Yuan · 1 shared paper, 2014 · strength 0.04
    • Paper Reduced expression of p21-activated protein kinase 1 correlates with poor histological differentiation in pancreatic ca… DOI 10.1186/1471-2407-14-650↗
15. Juan Han · 1 shared paper, 2014 · strength 0.04
    • Paper Reduced expression of p21-activated protein kinase 1 correlates with poor histological differentiation in pancreatic ca… DOI 10.1186/1471-2407-14-650↗
16. Feng Wang · 1 shared paper, 2014 · strength 0.04
    • Paper Reduced expression of p21-activated protein kinase 1 correlates with poor histological differentiation in pancreatic ca… DOI 10.1186/1471-2407-14-650↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.